{
  "title": "Patient-Reported Symptom Assessment and Early Chemotherapy Discontinuation in ... - medRxiv",
  "url": "https://www.medrxiv.org/content/10.1101/2025.10.07.25337194v1",
  "summary": [
    {
      "type": "bullet",
      "text": "More frequent completion of patient-reported symptom assessments post CTX initiation is associated with a lower risk of early discontinuation in gastrointestinal cancer patients receiving chemotherapy."
    },
    {
      "type": "bullet",
      "text": "After adjusting for demographic, clinical covariates, and time-varying bias, completing post-initiation assessments was linked to improved outcomes by lowering the cumulative risk of early discontinuation due to toxicity within 90 days."
    },
    {
      "type": "bullet",
      "text": "The findings suggest that regular symptom monitoring could be a practical strategy in standard care settings to reduce chemotherapy discontinuation rates and potentially improve patient outcomes."
    }
  ],
  "model": "granite4:tiny-h"
}